Krka revenue up 6% to record EUR 1.91bn, profit by 13% to EUR 353m in 2024
Ljubljana, 30 January - The drug maker Krka published an unaudited performance estimate for last year on Thursday, showing the group's revenue increased by 6% year-on-year to a record EUR 1.91 billion, while earnings before interest, tax, depreciation and amortization (EBITDA) reached EUR 518.2 million. Estimated net profit was up 13%, amounting to EUR 353.4 million.
Novo mesto
The logo of pharma company Krka.
Photo: Rasto Božič/STA
The rest of this news item is available to subscribers.
The news item consists of 778 characters (without spaces) or 140 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.